Jessica Vermeulen

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL”.

Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL

Cancer Cell(2021)10.1016/j.ccell.2021.10.006

N/A

5.4DataRank · unranked

314 citations

George W. Wright, Da Wei Huang, Brendan P. Hodkinson, Sriram Balasubramanian, Yue Fan +4 more

A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma

Blood Advances(2020)10.1182/bloodadvances.2020002827

N/A

0DataRank · unranked

416 citations

Hervé Avet‐Loiseau, Kenneth C. Anderson, Paola Neri, Bruno Paiva, Mehmet Samur +11 more

A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease

UNC Libraries(2020)10.17615/tfn8-cp59

N/A

0DataRank · unranked

0 citations

Ming Qi, Peter M. Voorhees, Frits van Rhee, Razelle Kurzrock, Luis Fayad +5 more

Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B‐cell lymphoma in the phase III clinical trial of R‐CHOP ± ibrutinib

British Journal of Haematology(2021)10.1111/bjh.17450

N/A

0DataRank · unranked

12 citations

Songbai Wang, Christopher Major, Brendan P. Hodkinson, Michael Schäffer, Laurie H. Sehn +10 more